View Older Stories

Apr 23, 2026 09:47AM Truist Reiterates Buy Rating on MBX Biosciences Inc (MBX)

Apr 13, 2026 12:27PM Stifel Reiterates Buy Rating on MBX Biosciences Inc (MBX), eyes MBX-4291 GLP Ph.1/2a trial results in Q4

Mar 13, 2026 06:25AM MBX Biosciences (MBX) Reiterated at Market Outperform by Citizens: Among Top '26 Picks

Mar 12, 2026 04:01PM Truist on MBX Biosciences Inc (MBX): 'We remain buyers'

Mar 12, 2026 04:00PM Truist Securities Reiterates Buy Rating on MBX Biosciences Inc (MBX): "We remain buyers of MBX following 4Q25 earnings"

Mar 12, 2026 03:56PM MBX (MBX) Reports Q4 Loss of $0.49

Mar 12, 2026 12:50PM Stifel Reiterates Buy Rating on MBX Biosciences Inc (MBX): "operating flexibility to reach multiple value-creating events this year"

Mar 12, 2026 11:30AM TD Cowen Reiterates Buy Rating on MBX Biosciences Inc (MBX): "confident" that canvu Phase III will be successful

Mar 10, 2026 08:03AM MBX Biosciences names Karen Basbaum as chief business officer

Mar 9, 2026 08:57AM Truist Securities Reiterates Buy Rating on MBX Biosciences Inc (MBX)

Feb 24, 2026 10:25AM UBS Reiterates Buy Rating on MBX Biosciences Inc (MBX)

Jan 16, 2026 06:36AM MBX Biosciences Inc (MBX) PT Raised to $88 at Guggenheim

Jan 13, 2026 07:22AM MBX Biosciences (MBX) Reiterated at Buy by Stifel: Advancing Obesity Portfolio

Jan 12, 2026 06:05AM MBX Biosciences to present pipeline updates at JP Morgan conference

Jan 7, 2026 12:44AM UBS Starts MBX Biosciences Inc (MBX) at Buy

Dec 19, 2025 07:38AM MBX Biosciences Inc (MBX) PT Raised to $50 at Stifel on PEP Platform Validation

Dec 4, 2025 06:51AM Goldman Sachs Starts MBX Biosciences Inc (MBX) at Sell

Nov 20, 2025 04:01AM Jefferies Reiterates Buy Rating on MBX Biosciences Inc (MBX)

Nov 6, 2025 04:32PM MBX (MBX) Reports Q3 Loss of $0.63

Nov 4, 2025 05:34AM TD Cowen Starts MBX Biosciences Inc (MBX) at Buy

Oct 15, 2025 06:52AM Oppenheimer Reiterates Outperform Rating on MBX Biosciences Inc (MBX)

Oct 14, 2025 04:02PM Truist Securities Starts MBX Biosciences Inc (MBX) at Buy

Oct 8, 2025 07:00AM Biotech and Medical Tech Stocks Report Breakthrough Clinical Trial Updates

Oct 7, 2025 07:55AM Citizens sees blockbuster potential in MBX Biosciences (MBX) post phase 2 data

Sep 24, 2025 06:35AM MBX Biosciences Inc (MBX) PT Raised to $56 at Mizuho

Sep 23, 2025 06:43AM MBX Biosciences Inc (MBX) PT Raised to $84 at Guggenheim

Sep 22, 2025 04:13PM MBX Biosciences (MBX) files for 10M share offering

Sep 22, 2025 06:56AM MBX Biosciences (MBX) Halted, News Pending

Aug 15, 2025 05:16AM Jefferies Assumes MBX Biosciences Inc (MBX) at Buy

Aug 5, 2025 05:14AM Mizuho Starts MBX Biosciences Inc (MBX) at Outperform

Jul 23, 2025 06:21AM Oppenheimer Reiterates Outperform Rating on MBX Biosciences Inc (MBX)

Jul 16, 2025 06:02AM Oppenheimer Starts MBX Biosciences Inc (MBX) at Outperform

Jul 16, 2025 04:18AM Citizens JMP Reiterates Market Outperform Rating on MBX Biosciences Inc (MBX)

Jul 2, 2025 04:12AM Citizens JMP Reiterates Market Outperform Rating on MBX Biosciences Inc (MBX)

Jun 24, 2025 09:17AM Stifel Reiterates Buy Rating on MBX Biosciences Inc (MBX)

Jun 16, 2025 08:03AM MBX Biosciences (MBX) Announces IND Submission of MBX 4291

Jun 12, 2025 07:13AM Stifel Reiterates Buy Rating on MBX Biosciences Inc (MBX)

May 13, 2025 06:30AM MBX (MBX) Reports Q1 Loss of $0.71

May 12, 2025 11:42AM Stifel Reiterates Buy Rating on MBX Biosciences Inc (MBX), PT $40, 'MBX has comfortable runway into mid-2027, well past the key AVAIL readout'

Apr 23, 2025 04:22AM Citizens JMP Reiterates Market Outperform Rating on MBX Biosciences Inc (MBX)

Apr 10, 2025 03:12AM Citizens JMP Starts MBX Biosciences Inc (MBX) at Market Outperform

Apr 7, 2025 08:02AM MBX Biosciences (MBX) Appoints Steve Hoerter to its Board

Mar 17, 2025 04:27PM MBX Biosciences (MBX) Misses Q4 EPS by 47c

Mar 5, 2025 08:01AM MBX Biosciences (MBX) Announces Additions to Leadership Team

Jan 7, 2025 07:01AM MBX Biosciences (MBX) Announces Positive Phase 1 Topline Results for MBX 1416

Nov 18, 2024 08:02AM MBX Biosciences (MBX) Announces Last Subject Last Visit in Phase 1 Trial of MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia

Nov 7, 2024 05:29PM (MBX) Misses Q3 EPS by 278c

Oct 8, 2024 03:45AM JPMorgan Starts MBX Biosciences Inc (MBX) at Overweight

Oct 8, 2024 02:48AM Jefferies Starts MBX Biosciences Inc (MBX) at Buy

Oct 8, 2024 02:47AM Guggenheim Starts MBX Biosciences Inc (MBX) at Buy

View Older Stories